ME Newswire / Business Wire
SAN DIEGO. - Friday, March 28th 2014
Pathway
Genomics Corporation, a San Diego-based CLIA and CAP accredited
clinical laboratory that offers genetic testing services globally,
announced that Nature Genetics founding editor Kevin Davies, Ph.D., has
joined its scientific advisory board.
“I have followed Pathway
closely for many years, reporting on the launch of the company in my
book, The $1,000 Genome,” said Davies. “I believe Pathway is poised to
make a major contribution to clinical diagnostics and improving the
wellness of millions of patients. I hope to make a modest contribution
to that effort.”
A highly respected science journalist, editor,
and publisher with more than 20 years of experience at the forefront of
advances in genetics and medicine, Davies is currently a vice president
with the American Chemical Society, the largest scientific society in
the world, where he serves as publisher of Chemical & Engineering
News, the society’s weekly magazine. He has also served as
editor-in-chief for Cell Press and was the founding editor of Bio-IT
World magazine.
“Kevin is a vital thought leader in the genomics
space and his work is a significant contribution to progress in the
field,” said Ardy Arianpour, Pathway Genomics’ chief strategy officer.
“We are exceptionally pleased to collaborate with an opinion leader of
his status.”
Born in London, Davies studied biochemistry and
molecular genetics at the Universities of Oxford and London before
moving to the United States. He conducted postdoctoral fellowships at
MIT and Harvard Medical School before moving into science publishing.
Davies is the author of three popular-science books on the medical and
societal implications of the genomics revolution, including Cracking the
Genomeand most recently The $1,000 Genome. He is a sought-after public
speaker and an occasional technical consultant to the film industry,
most recently serving as genetics consultant for the film Decoding Annie
Parker.
Pathway Genomics’ scientific advisory board consists of
leaders in various fields including oncology, pharmacogenomics,
endocrinology, bioinformatics, biostatistics, behavioral genetics,
nutrigenomics, and human epigenetics. To view the company’s full
scientific advisory board, visit www.pathway.com.
About Pathway Genomics Corporation
As
a CLIA and CAP accredited clinical laboratory based in San Diego,
California, Pathway Genomics provides physicians and their patients with
actionable and accurate genetic information to improve or maintain
health and wellness. Since its founding in 2008, Pathway Genomics has
become known for its dedication to innovation and commitment to medical
responsibility – making it a leader in the commercial genetic testing
industry. Pathway Genomics’ testing services cover a variety of
conditions including cardiac health, cancer risk, inherited diseases,
nutrition and exercise response, as well as drug response for specific
medications including those used in pain management and mental health.
For more about Pathway Genomics, visit www.pathway.com.
Contacts
Pathway Genomics Corporation
Zak Pugh, 858-217-4358
pr@pathway.com
www.pathway.com
Permalink: http://me-newswire.net/news/10471/en
No comments:
Post a Comment